|
Name
|
Size
|
Creator |
Creation Date
|
Labels |
|
|
PDF File
13584_2017_Article_138.pdf
|
315 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
315 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
PDF File
1472-6947-8-S1-S9.pdf
|
234 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
234 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
2017-02-17-EAG-Update.ppt.pptx
|
225 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
225 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
2017-03-30-EAG-Update.pptx
|
271 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
271 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
2017-04-Drug-Substance-AG-Status-Update.pptx
|
162 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
162 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
2017-04-Drug-Substance-EAG-Status-Update.pptx
|
163 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
163 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Word Document
2018-Jan-26-EAG-Drug-Substance-Update.docx
|
22 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
22 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
PDF File
2019-April-EAG-Device-Update.pdf
|
977 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
977 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
PDF File
2019-April-EAG-Product-Roles.pdf
|
951 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
951 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
Allergic disposition models.pptx
|
1.22 MB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
1.22 MB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
Allergy Topics.pptx
|
2.81 MB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
2.81 MB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
PDF File
Amyloid fibril proteins and amyloidosis chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature.pdf
|
470 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
470 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Word Document
artf6172_Imaging procedures _ELABORATION (3).docx
|
95 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
95 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
Arthropathy systemic disorders.pptx
|
730 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
730 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Word Document
Care plans discussion 20161117_MHA.docx
|
20 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
20 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Excel Spreadsheet
CombinedDisorderExercise2_Summary(2).xlsx
|
570 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
570 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
Complications and sequelae update.pptx
|
2.92 MB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
2.92 MB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
CVA due to occlusive thrombus or embolus models.pptx
|
1.02 MB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
1.02 MB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
PDF File
decision support malfunctions involving carvedilol.pdf
|
148 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
148 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Microsoft Powerpoint Presentation
Device complications.pptx
|
1003 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|
|
Version 1 (current)
|
1003 kB |
Jim Case |
2019-Oct-07, 17:46 |
|
|